U.S. Markets open in 3 hrs 29 mins
  • Gold

    1,804.50
    -2.30 (-0.13%)
     
  • EUR/USD

    1.1620
    +0.0005 (+0.0465%)
     
  • 10-Yr Bond

    1.6350
    0.0000 (0.00%)
     
  • Vix

    14.97
    -0.46 (-2.98%)
     
  • GBP/USD

    1.3793
    +0.0024 (+0.1752%)
     
  • USD/JPY

    114.0090
    +0.3100 (+0.2727%)
     
  • BTC-USD

    62,725.75
    +5.50 (+0.01%)
     
  • CMC Crypto 200

    1,508.01
    +1,265.33 (+521.40%)
     
  • FTSE 100

    7,267.09
    +44.27 (+0.61%)
     
  • Nikkei 225

    29,106.01
    +505.60 (+1.77%)
     

Weekly CEO Buys Highlight

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·4 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

- By Joy Hu

According to GuruFocus Insider Data, these were the largest CEO buys during the past week.

Carriage Services

Carriage Services Inc. (NYSE:CSV) CEO Melvin C. Payne bought 29,000 shares on Dec. 9 at a price of $30.02. The price of the stock has decreased by 1.03% since then.

Weekly CEO Buys Highlight
Weekly CEO Buys Highlight


Carriage Services is a leading provider of funeral and cemetery services and merchandise in the United States. It operates in two business segments: the Funeral Home Operations segment, which offers burial, cremation, consultation and other services; and the Cemetery Operations segment, which provides services such as mausoleum crypts, private estates, lawn crypt gardens, traditional single burial gravesites and burial vaults.

The company has a market cap of $533.88 million. Its shares traded at $29.71 with a price-earnings ratio of 52.03 as of Dec. 11.

Net income for the third quarter of 2020 was $5.5 million.

Cannae Holdings

Cannae Holdings Inc. (NYSE:CNNE) CEO Richard N. Massey bought 15,000 shares on Dec. 8 at a price of $42.33. Since then, the price of the stock has increased by 0.45%.

Weekly CEO Buys Highlight
Weekly CEO Buys Highlight

Cannae Holdings is a holding company that manages and operates a group of companies and investments. The company's reportable segments are Restaurant group, Ceridian, T-System, Dun & Bradstreet, Corporate and other.

The company has a market cap of $3.90 billion. Its shares traded at $42.52 with a price-earnings ratio of 2.71 as of Dec. 11.

Net loss for the quarter ended Sept. 30, 2020 was $14.9 million.

Golub Capital BDC

Golub Capital BDC Inc. (NASDAQ:GBDC) CEO David Golub bought 7,961 shares during the past week at the average price of $14.08.

Weekly CEO Buys Highlight
Weekly CEO Buys Highlight

Golub Capital BDC is an externally managed, closed-end, non-diversified investment management company. The company's investment objective is to generate current income and capital appreciation by investing in senior secured and one-stop loans in U.S. middle-market companies. It also invests in second lien and subordinated loans, warrants and minority equity securities in middle-market companies.

The company has a market cap of $2.3 billion. Its shares traded at $13.75 with a price-earnings ratio of 37.36 as of Dec. 11.

Net investment income during the three months ended Sept. 30 was $39.31 million.

Golub bought 4,000 shares on Nov. 27 at a price of $14.01; 3,755 shares on Dec. 1 at a price of $13.99; 4,000 shares on Dec. 2 at a price of $14.09; 3,961 shares on Dec. 7 at a price of $14.09; and 4,000 shares on Dec. 9 at a price of $14.08. The price of the stock has decreased by 2.34% since then.

Chairman Lawrence E. Golub bought 4,000 shares on Nov. 27 at a price of $14.01; 3,755 shares on Dec. 1 at a price of $13.99; 4,000 shares on Dec. 2 at a price of $14.09; 3,961 shares on Dec. 7 at a price of $14.09; and 4,000 shares on Dec. 9 at a price of $14.08. Since then, the price of the stock has decreased by 2.34%.

Chinook Therapeutics

Chinook Therapeutics Inc. (NASDAQ:KDNY) President and CEO Eric Dobmeier bought 4,000 shares on Dec. 9 at a price of $13.16. The price of the stock has increased by 1.22% since then.

Weekly CEO Buys Highlight
Weekly CEO Buys Highlight

Chinook Therapeutics is a clinical-stage biotechnology company. It is engaged in developing precision medicines for kidney diseases. The products of the company are focused on rare, severe chronic kidney disorders.

The company has a market cap of $561.55 million. Its shares traded at $13.32 as of Dec. 11.

Net loss for the third quarter of 2020 was $14.54 million.

Dobmeier also bought 2,000 shares on Nov. 23 at a price of $13.63. Since then, the price of the stock has decreased by 2.27%.

For the complete list of stocks bought by their company CEOs, go to: CEO Buys.

Disclosure: I do not own stock in any of the companies mentioned in the article.

Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.


This article first appeared on GuruFocus.